CAG repeat length polymorphism in the androgen receptor gene and breast cancer risk: data on Indian women and survey from the world

被引:10
作者
Rajender, Singh [1 ,2 ]
Francis, Amirtharaj [3 ]
Pooja, Singh [2 ]
Krupakar, Nallala [1 ]
Surekha, D. [4 ]
Reddy, Gopal [5 ,6 ]
Rao, D. Raghunatha [7 ]
Rao, Lakshmi [8 ]
Ramachandra, S. [9 ]
Vishnupriya, S. [4 ]
Ramalingam, K. [3 ]
Satyamoorthy, K. [10 ]
Thangaraj, Kumarasamy [1 ]
机构
[1] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India
[2] Cent Drug Res Inst, Div Endocrinol, Lucknow 226001, Uttar Pradesh, India
[3] Govt Arts Coll, Dept Adv Zool & Biotechnol, Madras, Tamil Nadu, India
[4] Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India
[5] MNJ Canc Hosp, Dept Biochem, Hyderabad, Andhra Pradesh, India
[6] Osmania Gen Hosp, Dept Biochem, Hyderabad, Andhra Pradesh, India
[7] Nizams Inst Med Sci, Hyderabad, Andhra Pradesh, India
[8] Manipal Univ, Kasturba Med Coll, Dept Pathol, Manipal, India
[9] Manipal Univ, Kasturba Med Coll, Dept Surg, Manipal, India
[10] Manipal Univ, Manipal Life Sci Ctr, Manipal, India
关键词
Breast cancer; Androgen receptor; CAG repeat polymorphism; ESTROGEN-RECEPTORS; ASSOCIATION; MUTATION; AR; SUSCEPTIBILITY; PROLIFERATION; TESTOSTERONE; CARCINOMA; FEATURES; CARRIERS;
D O I
10.1007/s10549-010-1263-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We analyzed the length of the CAG repeats of the androgen receptor gene in Indian women with breast cancer, and compared the data with that of other populations across the world in an attempt to find a potential pattern of association. The study was undertaken on 1,408 individuals comprising 747 breast cancer patients and 661 control individuals recruited from three southern states of India: Andhra Pradesh, Tamil Nadu, and Karnataka. The comparison revealed no difference in mean length of the repeat between cases and controls in any of the three groups or in the analysis of pooled data. No significant difference between pre- and post-menopausal cases in any of the three groups or in the analysis of pooled data was observed. Most of the studies to date support either positive association (longer repeats-increased disease risk) or no association, and only 2 out of 20 studies reported negative association (inverse correlation between repeat length and disease risk). Comparison of these data with those from other populations revealed several interesting facts. Particularly notable is that repeat length shows association with breast cancer risk in a population-specific manner with most of the studies on American and Canadian women showing positive association, whereas those on Australian and Israeli women showing no association. Only one study had been conducted on other populations including Asians/South Asians; this restricted us from finding any patterns of association in these populations.
引用
收藏
页码:751 / 760
页数:10
相关论文
共 46 条
[1]   OVARIAN AND ADRENAL CONTRIBUTION TO PERIPHERAL ANDROGENS DURING MENSTRUAL-CYCLE [J].
ABRAHAM, GE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1974, 39 (02) :340-346
[2]  
ADASHI EY, 1994, FERTIL STERIL, V62, P20
[3]   Combined profile of the tandem repeats CAG, TA and CA of the androgen and estrogen receptor genes in breast cancer [J].
Anghel, Andrei ;
Raica, Marius ;
Marian, Catalin ;
Ursoniu, Sorin ;
Mitrasca, Oana .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2006, 132 (11) :727-733
[4]  
[Anonymous], 1997, International Union against Cancer (UICC). TNM Classification of Malignant Tumours
[5]   The prevalence and features of the polycystic ovary syndrome in an unselected population [J].
Azziz, R ;
Woods, KS ;
Reyna, R ;
Key, TJ ;
Knochenhauer, ES ;
Yildiz, BO .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2745-2749
[6]   HISTOLOGICAL GRADING AND PROGNOSIS IN BREAST CANCER - A STUDY OF 1409 CASES OF WHICH 359 HAVE BEEN FOLLOWED FOR 15 YEARS [J].
BLOOM, HJG ;
RICHARDSON, WW .
BRITISH JOURNAL OF CANCER, 1957, 11 (03) :359-&
[7]   A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition [J].
Burger, HG ;
Dudley, EC ;
Cui, JS ;
Dennerstein, L ;
Hopper, JL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (08) :2832-2838
[8]   A comprehensive analysis of the androgen receptor gene and risk of breast cancer:: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3) [J].
Cox, David G. ;
Blanche, Helene ;
Pearce, Celeste L. ;
Calle, Eugenia E. ;
Colditz, Graham A. ;
Pike, Malcolm C. ;
Albanes, Demetrius ;
Allen, Naomi E. ;
Amiano, Pilar ;
Berglund, Goran ;
Boeing, Heiner ;
Buring, Julie ;
Burtt, Noel ;
Canzian, Federico ;
Chanock, Stephen ;
Clavel-Chapelon, Francoise ;
Feigelson, Heather Spencer ;
Freedman, Matthew ;
Haiman, Christopher A. ;
Hankinson, Susan E. ;
Henderson, Brian E. ;
Hoover, Robert ;
Hunter, David J. ;
Kaaks, Rudolf ;
Kolonel, Laurence ;
Kraft, Peter ;
LeMarchand, Loic ;
Lund, Eiliv ;
Palli, Domenico ;
Peeters, Petra H. M. ;
Riboli, Elio ;
Stram, Daniel O. ;
Thun, Michael ;
Tjonneland, Anne ;
Trichopoulos, Dimitrios ;
Yeager, Meredith .
BREAST CANCER RESEARCH, 2006, 8 (05)
[9]   Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers:: association with breast/ovarian cancer phenotype [J].
Dagan, E ;
Friedman, E ;
Paperna, T ;
Carmi, N ;
Gershoni-Baruch, R .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 (11) :724-728
[10]  
De Abreu FB, 2007, ANTICANCER RES, V27, P1199